ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 503,27
-2,66%
Dow Jones
38 589,16
-0,15%
DAX
18 002,02
-1,43%
Brent Oil
82,275
0,00%
Bitcoin
66 060,06
0,08%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Guardant Health Inc (GH)

  7. Guardant Health Inc (GH) Actualités

GH

Guardant Health (GH)

Guardant Health Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:GH
DateHeureSourceTitreSymboleSociété
14/06/202415h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GHGuardant Health Inc
14/06/202403h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GHGuardant Health Inc
04/06/202422h12Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:GHGuardant Health Inc
04/06/202414h05Business WireGuardant Health introduces new Guardant360 TissueNext test with nearly 500 biomarkers to identify more treatment options for patients with advanced cancerNASDAQ:GHGuardant Health Inc
03/06/202415h18Business WireGuardant Health and Washington University to present study at 2024 ASCO meeting highlighting utility of ctDNA to address racial inequities in the use of targeted therapies and enrollment in clinical trialsNASDAQ:GHGuardant Health Inc
31/05/202414h05Business WireGuardant Health Named to TIME100 Most Influential CompaniesNASDAQ:GHGuardant Health Inc
30/05/202414h05Business WireGuardant Health to Present Studies at 2024 ASCO Annual Meeting Highlighting Contributions of Its Blood Tests and Real-World Data to Advancing Precision Oncology and Cancer ScreeningNASDAQ:GHGuardant Health Inc
24/05/202401h03Business WireFDA Advisory Committee Panel Strongly Recommends Approval of Shield™ Blood Test for Colorectal Cancer Screening as a Primary Non-Invasive Screening OptionNASDAQ:GHGuardant Health Inc
23/05/202413h05Business WireGuardant Health Stock Trading Temporarily Halted; FDA Panel to Assess Premarket Approval Application for Shield Blood Test for Colorectal Cancer ScreeningNASDAQ:GHGuardant Health Inc
22/05/202422h05Business WireGuardant Health to Participate in Upcoming Investor ConferencesNASDAQ:GHGuardant Health Inc
21/05/202414h44Business WireGuardant Health erhält EU-IVDR-Zertifizierung für Flüssigbiopsie Guardant360® CDx zur Erstellung von Tumormutationsprofilen für alle soliden Krebsarten und therapiebegleitende Diagnostika-IndikationenNASDAQ:GHGuardant Health Inc
21/05/202414h44Business WireGuardant Health reçoit la certification IVDR de l’UE pour la biopsie liquide Guardant360® CDx destinée au profilage des mutations tumorales dans tous les cancers solides et les indications de diagnostic compagnonNASDAQ:GHGuardant Health Inc
21/05/202414h05Business WireGuardant Health Receives EU IVDR Certification for Guardant360® CDx Liquid Biopsy for Tumor Mutation Profiling Across All Solid Cancers and Companion Diagnostic IndicationsNASDAQ:GHGuardant Health Inc
17/05/202414h05Business WireGuardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:GHGuardant Health Inc
16/05/202414h05Business WireGuardant Health to present real-world data supporting performance of Shield™ blood test for colorectal cancer screening at 2024 Digestive Disease WeekNASDAQ:GHGuardant Health Inc
09/05/202422h59Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GHGuardant Health Inc
09/05/202422h05Business WireGuardant Health Reports First Quarter 2024 Financial Results and Increases 2024 Revenue GuidanceNASDAQ:GHGuardant Health Inc
07/05/202414h00Business WireGuardant Health Surpasses 500 Peer-Reviewed Publications MilestoneNASDAQ:GHGuardant Health Inc
22/04/202414h52Business WireFDA Advisory Panel Review of Guardant Health’s Shield™ Blood Test to Screen for Colorectal Cancer to Be Held on May 23NASDAQ:GHGuardant Health Inc
18/04/202422h05Business WireGuardant Health to Report First Quarter 2024 Financial Results on May 9, 2024NASDAQ:GHGuardant Health Inc
03/04/202414h05Business WireGuardant Health to Present Data Highlighting Application of Epigenomics to Advance Precision Oncology at 2024 AACR Annual MeetingNASDAQ:GHGuardant Health Inc
13/03/202422h00Business WireGuardant Health ECLIPSE Study Data Demonstrating Efficacy of Shield Blood-based Test for Colorectal Cancer Screening to be Published in The New England Journal of MedicineNASDAQ:GHGuardant Health Inc
01/03/202411h30Business WireNew Survey: Patients and Physicians Overwhelmingly Agree Blood Tests Could Help Close the Colorectal Cancer Screening GapNASDAQ:GHGuardant Health Inc
23/02/202422h10Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:GHGuardant Health Inc
22/02/202423h23Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:GHGuardant Health Inc
22/02/202422h05Business WireGuardant Health Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 OutlookNASDAQ:GHGuardant Health Inc
14/02/202401h46Edgar (US Regulatory)Form 5 - Annual statement of changes in beneficial ownership of securitiesNASDAQ:GHGuardant Health Inc
01/02/202422h05Business WireGuardant Health to Report Fourth Quarter and Full Year 2023 Financial Results on February 22, 2024NASDAQ:GHGuardant Health Inc
18/01/202423h09Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:GHGuardant Health Inc
17/01/202414h05Business WireGuardant Health to present data at ASCO GI supporting use of liquid biopsy to predict colon cancer recurrenceNASDAQ:GHGuardant Health Inc
 Showing the most relevant articles for your search:NASDAQ:GH

Dernières Valeurs Consultées

USOTC
IBXNF
Ibex Technologies (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés